Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway.
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis.
Immunomodulation by Sub-Chronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.
Uhthoff's phenomenon as the first manifestation of multiple sclerosis in an adult male.
The use of immune modulating drugs for the treatment of multiple sclerosis.
In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology.
Neurological involvement in primary sjögren syndrome: a focus on central nervous system.
Central canal ependymal cells proliferate extensively in response to traumatic spinal cord injury but not demyelinating lesions.
Influence of drugs on gap junctions in glioma cell lines and primary astrocytes in vitro.
Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.
Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
Acute disseminated encephalomyelitis following seasonal influenza vaccination in an elderly patient: a case report.
Severe Disability in Patients with Relapsing-Remitting Multiple Sclerosis Is Associated with Profound Changes in the Regulation of Leptin Secretion.
Teriflunomide for the treatment of multiple sclerosis.
Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis.
Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis.
Neurological and psychiatric disorders as a neuroglial failure.
Ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, inhibits proliferation and differentiation of th17 cells.
Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.
Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
Lower urinary tract symptoms associated with neurological conditions: Observations on a clinical sample of outpatients neurorehabilitation service.
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.
Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems.
Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis.
FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity.

Pages